Ahmet Oguzhan Kucuk
Overview
Explore the profile of Ahmet Oguzhan Kucuk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kucuk A, Hatinoglu N, Apaydin U, Altunalan T, Pehlivanlar Kucuk M
Nurs Crit Care
. 2024 Oct;
PMID: 39449552
Background: Early mobilization are key components of the ABCDEF Care Bundle and critical treatments to reduce acquired muscle weakness, delirium and prolonged intensive care unit (ICU) stay. Aim: This study...
2.
Kangalgil M, Kucuk A, Ulusoy H, Ozcelik A
Nutr Clin Pract
. 2023 Oct;
39(3):579-588.
PMID: 37877164
Background: Skeletal muscle loss is associated with adverse outcomes in critically ill patients and risk factors of acute skeletal muscle loss are not well described. This study aims to determine...
3.
Gul F, Kasapoglu U, Sabaz M, Ay P, Oktay B, Caliskan G, et al.
Balkan Med J
. 2023 Oct;
40(6):435-444.
PMID: 37867428
Background: Vaccines against coronavirus disease-19 (COVID-19) have been effective in preventing symptomatic diseases, hospitalizations, and intensive care unit (ICU) admissions. However, data regarding the effectiveness of COVID-19 vaccines in reducing...
4.
Cebeci G, Cebeci H, Pehlivanlar Kucuk M, Kucuk A, Bayrak I, Ulger F
J Coll Physicians Surg Pak
. 2022 Oct;
32(10):1300-1307.
PMID: 36205275
Objective: To investigate the efficacy of neuromuscular electrical stimulation (NMES) application in preventing muscle wasting in intensive care unit (ICU) patients diagnosed with sepsis/septic shock. Study Design: A single-centre, unblinded,...
5.
Pehlivanlar Kucuk M, Kucuk A, Pehlivanlar A, Murtezaoglu S, Coban K, Kilic G, et al.
Turk J Med Sci
. 2022 Sep;
52(1):39-49.
PMID: 36161598
Background: In this study, the efficacy of an IL-6 antagonist, Tocilizumab, administered in the early period was studied in intensive care patients with COVID-19 pneumonia followed by hypoxic and systemic...
6.
Kucuk A, Pehlivanlar Kucuk M, Pehlivanlar A, Murtezaoglu S, Coban K, Topaloglu O, et al.
Tuberk Toraks
. 2022 Apr;
70(1):63-75.
PMID: 35362306
Introduction: This study aimed to evaluate the epidemiological, clinical, laboratory characteristics and treatment and clinical outcomes of severe COVID19 cases from a 3rd degree intensive care unit in Turkey. Materials...
7.
Kucuk A, Pehlivanlar Kucuk M, Aycicek O, Altun G, Ozdemir A
Turk J Emerg Med
. 2022 Mar;
22(1):36-43.
PMID: 35284694
Objectives: In this article, the results of severe coronavirus disease 2019 (COVID-19) cases followed with extracorporeal membrane oxygenation (ECMO) support in a 3-month period in the third wave when there...
8.
Pehlivanlar Kucuk M, Kucuk A, Komurcu O, Dikmen Y, Kadioglu M, Uzan C, et al.
Tuberk Toraks
. 2021 Sep;
69(3):349-359.
PMID: 34581156
Introduction: The aim of this study was to reveal the effect of the individual's lifestyle and personality traits on the disease process in patients with sepsis and to have clinical...
9.
Ulusoy H, Kangalgil M, Kucuk A, Ozdemir A, Caner Karahan S, Yaman S, et al.
Clin Nutr
. 2021 Jul;
40(7):4569-4578.
PMID: 34229261
Background & Aims: Intravenous lipid emulsions in parenteral nutrition may cause different metabolic responses and immune effects in critically ill patients with sepsis. The aim of this study is to...
10.
Pehlivanlar Kucuk M, Ozturk C, Koylu Ilkaya N, Kucuk A, Ergul D, Ulger F
Braz J Anesthesiol
. 2021 Apr;
72(1):29-36.
PMID: 33905798
Background And Objectives: The objective of this study was to investigate the use of early APRV mode as a lung protective strategy compared to conventional methods with regard to ARDS...